B. Erdönmez Et Al. , "Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy," ACS OMEGA , vol.8, no.22, pp.20056-20065, 2023
Erdönmez, B. Et Al. 2023. Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy. ACS OMEGA , vol.8, no.22 , 20056-20065.
Erdönmez, B., Altıntop, M. D., Akalın Çiftçi, G., Özdemir, A., & Ece, A., (2023). Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy. ACS OMEGA , vol.8, no.22, 20056-20065.
Erdönmez, Burak Et Al. "Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy," ACS OMEGA , vol.8, no.22, 20056-20065, 2023
Erdönmez, Burak Et Al. "Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy." ACS OMEGA , vol.8, no.22, pp.20056-20065, 2023
Erdönmez, B. Et Al. (2023) . "Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy." ACS OMEGA , vol.8, no.22, pp.20056-20065.
@article{article, author={Burak Erdönmez Et Al. }, title={Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy}, journal={ACS OMEGA}, year=2023, pages={20056-20065} }